Veterinary Big Data stakeholder forum

Table of contents

Date: 01/06/2021 to 02/06/2021
Location: Virtual event

Live broadcast - 1 June - 14:00-17:45 CEST and 2 June - 09:00-17:20 CEST

 

You should see the live broadcast on pressing the 'play' icon in the video window, or a message stating that we are not currently broadcasting.

To optimise video quality, once the video is playing we recommend clicking on the ‘HD’ symbol in the video window then selecting the '720p' option.

If the video window is blank, or if you experience other difficulties viewing the broadcast, please try connecting directly to the IBM channel.

For technical information about the required network security settings, please see this IBM help page.

For further assistance, please consult the EMA service desk.

In recent years, reflections have progressed on how medicines regulation could be enhanced by digital technologies. Whilst substantial advancements occurred in the use of such solutions in the regulation of medicines for human use, the use of digital technologies in the veterinary regulatory domain is an unexplored yet potentially fertile territory.

The Agency is organising the Veterinary Big Data Stakeholder forum as a first opportunity to bring together regulators, the pharmaceutical industry, farm management system providers, academia, consumers and practitioners, to:

  • build awareness on the use of innovative digital technologies in the veterinary regulatory environment;
  • share needs, ambitions and opportunities;
  • inspire future activities shaping the development of the European Veterinary Big Data Strategy.

Registration

Registration is open until 25 May 2021. 

If you want to participate on both days 1 and 2 June, please register for both dates via the Webex links below.

Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to the European Medicines Agency instead.

Order